on Yandex N.V. (NASDAQ:YNDX)
Nebius Honors AI Innovations in Healthcare at AI Discovery Awards
Nebius, the AI cloud company, held its expanded AI Discovery Awards to recognize innovations in healthcare and life sciences. With $1.4 million in compute and inference credits, the awards highlighted pioneers in biopharma, genomics, digital health, medical devices, and medical imaging.
The 2026 program introduced categories for Medical Devices and Medical Imaging, signaling AI's growing impact in these fields. Noteworthy winners included Phylo, Corti.ai, Omniscope, Real Time Imaging Systems, and Nucleo Research. Each received substantial compute credits to support their advancements.
Alongside the awards, Nebius previewed its Scientific AI and Healthcare Platform, tailored for the unique needs of healthcare and life sciences sectors. This platform aims to assist startups from research to market-ready stages, with targeted infrastructure and support.
The AI Discovery Awards drew 647 global entries, assessed on the usage of AI, technical innovation, and business potential. Regional Trailblazer awards were also introduced, further encouraging global AI advancements in healthcare.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Yandex N.V. news